Topics

Risk of Syncopal Relapses in Patients Treated With Permanent Pacing for Bradyarrhythmic Syncope

2020-01-22 12:12:59 | BioPortfolio

Summary

Prospective, multicenter, observational registry designed to collect data on syncopal relapses in patients undergoing pacemaker implantation for bradyarrhythmic syncope.

Description

Prospective, multicenter, observational registry designed to collect data on syncopal relapses in patients undergoing pacemaker implantation for bradyarrhythmic syncope. All consecutive patients aged ≥18 years who underwent pacemaker implantation for syncope of bradyarrhythmic aetiology (proven or presumed) at participating centers from January 2010 to December 2013 were enrolled in the registry. During follow-up the occurrence of the first syncopal relapse after pacemaker implantation is recorded.

Study Design

Conditions

Syncope

Intervention

Clinic follow-up

Location

"Card. G. Panico" Hospital
Tricase
Lecce
Italy
73039

Status

Active, not recruiting

Source

Azienda Ospedaliera Cardinale G. Panico

Results (where available)

View Results

Links

Published on BioPortfolio: 2020-01-22T12:12:59-0500

Clinical Trials [498 Associated Clinical Trials listed on BioPortfolio]

Electrophysiological Mechanisms and Inhibitory Cardiac Syncope

OBJECTIVES: To evaluate syncope recurrence at follow up in patients with a positive cardio inhibitory response to the head up tilt testing (HUT) evaluation. METHODS: 36 consecutive patien...

Prevalence of PE in ED Patients With Isolated Syncope

Syncope is a rapid onset, transient, loss of consciousness with a short duration. This symptom has been reported to be a specific presentation of patients with pulmonary embolism. However,...

Validation of the San Francisco Syncope Rule

This study was designed to validate the "San Francisco Syncope Rule". This set of rules was derived by Quinn et. al. to help guide the treatment of patients evaluated in the Emergency Dep...

Prevention of Syncope Trial 6 - Atomoxetine in Vasovagal Syncope

Objective: To determine if atomoxetine 40 mg bid in patients ≥18 years old with recurrent vasovagal syncope will better prevent syncope during tilt testing than placebo.

A Proof of Principal Study of Atomoxetine for the Prevention of Vasovagal Syncope

Syncope affects about 50% of Canadians, is the cause of 1-2% of emergency room visits, and probably is responsible for CDN $250 million in health care spending each year.There is no known ...

PubMed Articles [4852 Associated PubMed Articles listed on BioPortfolio]

Different Types of Syncope Presenting to Clinic: Do We Miss Cardiac Syncope?

In the outpatient setting, differentiation of cardiac syncope (CS) from other more common forms of syncope is difficult, particularly in the elderly. We examined the frequency of the different types o...

Prevalence of venous thromboembolism in admissions and readmissions with and without syncope: a nationwide cohort study.

The Pulmonary Embolism in Syncope Italian Trial reported 17.3% prevalence of pulmonary embolism (PE) in patients admitted with syncope. We investigated the prevalence of venous thromboembolism [VTE, i...

Use of the Clinical Examination in the Diagnosis of Cardiac Syncope.

Syncope or transient loss of consciousness is a common problem seen in the emergency department (ED), accounting for 1% to 1.5% of ED visits annually. Cardiac syncope caused by cerebral hypoperfusion ...

60-Year-Old Man With Syncope, Abdominal Pain, and Hematochezia.

A systematic review on recurrent cardioinhibitory vasovagal syncope: does pacing therapy break the fall?

Vasovagal reflex is the most common cause of syncope. Pacemaker with rate drop response (RDR) or closed-loop stimulation (CLS) anti-syncope algorithms have been studied in recurrent vasovagal syncope ...

Medical and Biotech [MESH] Definitions

An approach, process, or methodology which emphasizes credible evidence and the best available scientific knowledge, judiciously integrated to achieve the best possible outcomes in structural design. For example, the design of a new OUTPATIENT CLINIC might incorporate a review of published research on outpatient clinic design, decisions on similar past projects, along with interviews with staff and consumers.

A transient loss of consciousness and postural tone caused by diminished blood flow to the brain (i.e., BRAIN ISCHEMIA). Presyncope refers to the sensation of lightheadedness and loss of strength that precedes a syncopal event or accompanies an incomplete syncope. (From Adams et al., Principles of Neurology, 6th ed, pp367-9)

Study subjects in COHORT STUDIES whose outcomes are unknown e.g., because they could not or did not wish to attend follow-up visits.(from Dictionary of Epidemiology, 5th ed.)

A condition of fainting spells caused by heart block, often an atrioventricular block, that leads to BRADYCARDIA and drop in CARDIAC OUTPUT. When the cardiac output becomes too low, the patient faints (SYNCOPE). In some cases, the syncope attacks are transient and in others cases repetitive and persistent.

Healthcare setting managed by medical personnel in training.

More From BioPortfolio on "Risk of Syncopal Relapses in Patients Treated With Permanent Pacing for Bradyarrhythmic Syncope"

Quick Search

Searches Linking to this Trial